Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Red light therapy for IVF embryos: a new hope for fertility?

NCT ID NCT07311928

Disease control Sponsor: Columbia University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether shining a special red light on embryos during IVF can help them grow better. As women age, the energy centers in their cells (mitochondria) weaken, making it harder for embryos to develop. The light therapy aims to boost that energy. Researchers will compare embryos from 200 women who receive the light treatment versus those who don't, looking at how many become usable for transfer.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
photobiomodulation (low-level red light therapy)
What this could lead to
If it works, this could improve the number of usable embryos for IVF, potentially increasing pregnancy chances for older women.
What could go wrong
This is an early-stage study focused on embryo development, not live birth rates. The light therapy may not improve outcomes, and results may not apply to all IVF patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 48 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female age between 18-48 years at time of IVF/ICSI cycle * Undergoing blastocyst culture and PGT-A * Using own oocytes * Have at least two fertilized eggs available for randomization * Consenting to embryo-level randomization * Plan to transfer euploid embryo within 6 months Exclusion Criteria: * Use of donor eggs * Known uterine or genetic anomalies * Refusal of randomization or request for non-standard handling

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ivf outcomes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ivf outcomes

Contacts and locations

Locations

  • Columbia University Fertility Center

    New York, New York, 10019, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.